Queen Elizabeth II Health Sciences Centre — Halifax, Nova Scotia

Public research footprint of Queen Elizabeth II Health Sciences Centre, compiled from the ClinicalTrials.gov public registry.

221

Registered studies

Active

Recruiting now

131

Completed

Stopped or withdrawn

Most-studied conditions

Carcinoma, Non-Small-Cell Lung · Diffuse Large B-Cell Lymphoma · Multiple Myeloma · Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute…

Recently updated registry entries

NCT06852222 — A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With… (Recruiting)
NCT07258511 — A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3… (Recruiting)
NCT06623422 — A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Queen Elizabeth II Health Sciences Centre?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.